En­sur­ing con­sis­ten­cy in prod­uct qual­i­ty: How FDA's re­quests for more in­fo will be for­mal­ized

Mak­ing sure a phar­ma spon­sor and the FDA are on the same page when it comes to a new drug de­vel­op­ment pro­gram, par­tic­u­lar­ly around man­u­fac­tur­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.